首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

1271184

多囊卵巢綜合徵 (PCOS) 治療市場按藥物類別按分銷渠道按地區2023-2030規模、份額、前景和機會分析

Polycystic Ovary Syndrome Treatment Market, By Drug Class, By Distribution Channel, By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年04月03日 | 出版商:

Coherent Market Insights | 英文 177 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

多囊卵巢綜合徵 (PCOS) 可以描述為由於內分泌失調而在卵巢中形成充滿液體的小囊。患有 PCOS 的育齡婦女受到影響。 PCOS 陽性的女性更容易發生流產、妊娠糖尿病、妊娠高血壓、先兆子癇和早產。此外，患有 PCOS 的女性可能會出現月經週期不規律、雄激素（性激素）水平升高、頭髮過度生長、痤瘡和肥胖。

患有 PCOS 的女性更容易出現嚴重的健康問題。其中包括 2 型糖尿病、高血壓、心血管疾病和子宮癌。患有 PCOS 的女性通常難以懷孕（不孕）。

市場動態

口服避孕藥的有效使用和產品價值的提高可能會在預測期內推動多囊卵巢綜合徵 (PCOS) 治療市場。例如，2022 年 8 月，發表在 NCBI 上的一篇論文發現，口服避孕藥 (OCs) 治療 PCOS 的主要作用機制是控制月經。這些藥物還通過降低睪丸激素水平來減少多毛症和痤瘡。因此，口服避孕藥已成為多囊卵巢綜合徵的主要治療方法。

此外，人們對治療多囊卵巢綜合徵 (PCOS) 的新機制的認識不斷提高，預計將在預測期內推動市場增長。例如，根據中國婦產科於 2020 年 11 月發表的一項研究，電針 (EA) 干預通過調節脂質代謝調節劑 SREBP1 來減少 IR、線粒體功能障礙和氧化應激。這種改善減輕了大鼠的 PCOS 樣症狀。我們的研究結果揭示了電針治療 PCOS 的一種新的保護機制。

這項研究的主要特點

本報告對全球多囊卵巢綜合徵 (PCOS) 治療市場進行了深入分析，揭示了以 2022 年為基準年的預測期 (2023-2030) 的市場規模和復合年增長率 (CAGR) .%）。
它闡明了各個細分市場的潛在收入機會，並概述了該市場具有吸引力的投資建議矩陣。
它還提供有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
根據公司亮點、產品組合、主要亮點、財務業績和戰略等參數，介紹全球多囊卵巢綜合徵 (PCOS) 治療市場的主要參與者。
本研究報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以通過用於分析全球多囊卵巢綜合徵 (PCOS) 治療市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

調查目的
先決條件
縮寫

第二章市場展望

報告概述
- 市場定義和範圍
執行摘要
- 市場概況：按藥物類別
- 市場概況：按分銷渠道
- 市場概況：按地區
連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

市場動態
- 司機
- 約束因素
- 市場吸引力分析
- 市場機會
流行病學
監管情景
產品發布
合併、收購、聯合研究
主要發展
市場趨勢
害蟲分析
波特的分析
風險和副作用
主要市場參與者的新投資
管道分析
供應鏈分析
價格分析
品牌分析

第 4 章全球多囊卵巢綜合徵 (PCOS) 治療市場 - 冠狀病毒 (COVID-19) 大流行的影響

經濟影響
COVID-19 的流行病學特徵
對臨床試驗的影響

第 5 章全球多囊卵巢綜合徵 (PCOS) 藥物市場：按藥物類別，2017-2030

口服避孕藥
胰島素增敏劑
抗抑鬱藥
鳥氨酸脫羧□抑製劑
芳香化□抑製劑和 SERM
利尿劑

第 6 章。全球多囊卵巢綜合徵 (PCOS) 藥物市場：按分銷渠道，2017-2030

醫院藥房
零售藥房
在線藥店

第 7 章。全球多囊卵巢綜合徵 (PCOS) 藥物市場：按地區劃分，2017-2030

北美
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲
歐洲
英國
德國
意大利
法國
西班牙
俄羅斯
其他歐洲
亞太地區
中國
印度
日本
東盟
澳大利亞
韓國
其他亞太地區
中東
海灣合作委員會
以色列
其他中東地區
非洲
北非
中非
南非

第八章競爭格局

Sanofi S.A.
Amneal Pharmaceuticals, Inc.
Laurus Labs Limited
Zydus Pharmaceuticals, Inc.
Prasco Laboratories
Reddy's Laboratories
Cadila Pharmaceuticals
Novartis International AG
Concordia Pharmaceuticals Inc.
Covis Pharmaceuticals, Inc.
Cardinal Health
Aphena Pharma Solutions Tennessee, Inc.
Mylan N.V.
McKesson Corporation
Teva Pharmaceutical Industries Ltd
Lupin Pharmaceutical
Sun Pharmaceutical Industries Ltd.

第 9 章

調查方法
關於出版商

簡介目錄

Product Code: CMI1589

Polycystic Ovarian Syndrome (PCOS) can be described as small sacs filled with fluid develop on the ovaries as a result of the endocrine system condition. Women with PCOS who are of childbearing age are affected. PCOS-positive women are more likely to experience miscarriage, gestational diabetes, pregnancy-induced hypertension, preeclampsia, and early birth. Moreover, women with PCOS may experience irregular menstrual cycles, elevated androgen (sex hormone) levels, excessive hair growth, acne, and obesity.

Women who have PCOS are more likely to develop serious health issues. These include type 2 diabetes, high blood pressure, heart and blood vessel problems, and uterine cancer. Women suffering from PCOS frequently struggle to conceive (fertility).

Market Dynamics

Effective use of oral contraceptives and increasing product value can drive the polycystic ovary syndrome (PCOS) treatment market over the forecast period. For instance, in August 2022, an article was published in the NCBI, according to which, for the treatment of PCOS, the major mechanism of action of oral contraceptives (OCs) is to control menstruation. These drugs also reduce hirsutism and acne by lowering testosterone levels. Thus, oral contraceptives are primary treatment for the polycystic ovary syndrome.

Moreover, rising awareness about novel mechanisms in the treatment of Polycystic Ovary Syndrome (PCOS) is anticipated to boost the growth of the market over the forecast period. For instance, according to research study published by Department of Obstetrics and Gynecology, China in November 2020, stated that the electroacupuncture (EA) intervention alleviated PCOS-like symptoms in rats by improving IR, mitochondrial dysfunction and oxidative stress through regulation of SREBP1, a regulator of lipid metabolism. The study findings illuminate the novel protective mechanisms of EA in the treatment of PCOS.

Key features of the study:

This report provides in-depth analysis of the global Polycystic Ovary Syndrome (PCOS) Treatment market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Global Polycystic Ovary Syndrome (PCOS) Treatment Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study Key companies covered as a part of this study Sanofi S.A., Amneal Pharmaceuticals, Inc., Laurus Labs Limited, Zydus Pharmaceuticals, Inc., Prasco Laboratories, Dr. Reddy's Laboratories, Cadila Pharmaceuticals, Novartis International AG, Concordia Pharmaceuticals Inc., Evotec SE, Covis Pharmaceuticals, Inc., Cardinal Health, Aphena Pharma Solutions Tennessee, Inc., Mylan N.V., McKesson Corporation, Teva Pharmaceutical Industries Ltd, Lupin Pharmaceutical and Sun Pharmaceutical Industries Ltd., Bayer AG, and other prominent players Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Polycystic Ovary Syndrome (PCOS) Treatment Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Polycystic Ovary Syndrome (PCOS) Treatment Market

Detailed Segmentation:

Global Polycystic Ovary Syndrome (PCOS) Treatment Market, By Drug Class:
- Oral contraceptives
- Insulin Sensitizing Agents
- Anti-Depressants
- Ornithine Decarboxylase Inhibitors
- Aromatase Inhibitors & SERMs
- Diuretics
Global Polycystic Ovary Syndrome (PCOS) Treatment Market By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Polycystic Ovary Syndrome (PCOS) Treatment Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country/Region:
- South Africa
- Central Africa
- North Africa
Company Profiles
- Sanofi S.A.*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Amneal Pharmaceuticals, Inc.
- Laurus Labs Limited
- Zydus Pharmaceuticals, Inc.
- Prasco Laboratories
- Reddy's Laboratories
- Cadila Pharmaceuticals
- Novartis International AG
- Concordia Pharmaceuticals Inc.
- Covis Pharmaceuticals, Inc.
- Cardinal Health
- Aphena Pharma Solutions Tennessee, Inc.
- Mylan N.V.
- McKesson Corporation
- Teva Pharmaceutical Industries Ltd
- Lupin Pharmaceutical
- Sun Pharmaceutical Industries Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Attractiveness Analysis
- Market Opportunities
Epidemiology
Regulatory Scenario
Product Launches
Merger, Acquisition, Collaborations
Key Developments
Market Trends
PEST Analysis
PORTER'S Analysis
Risk and Adverse Effects
New Investments by Major Market Players
Pipeline Analysis
Supply Chain Analysis
Pricing Analysis
Brand Analysis

4. Global Polycystic Ovary Syndrome (PCOS) Treatment Market - Impact of Coronavirus (Covid-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Impact on Clinical Trials

5. Global Polycystic Ovary Syndrome (PCOS) Treatment Market, By Drug Class, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Oral contraceptives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Insulin Sensitizing Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Anti- Depressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Ornithine Decarboxylase Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Aromatase Inhibitors & SERMs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Diuretics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Polycystic Ovary Syndrome (PCOS) Treatment Market, By Distribution Channel, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030(%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segments Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Polycystic Ovary Syndrome (PCOS) Treatment Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2023 and 2030(%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa

8. Competitive Landscape

Sanofi S.A.*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Amneal Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Laurus Labs Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zydus Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Prasco Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Reddy's Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Cadila Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novartis International AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Concordia Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Covis Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Cardinal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Aphena Pharma Solutions Tennessee, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
McKesson Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Teva Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Lupin Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies